See All Slides - tctmd.com

Slides

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2013

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Presenter: Yoshinobu Onuma

October 31, 2013

Presentation TCT 2013

Case 3: Acute Myocardial Infarction: Is There a Role for Routine IVUS/OCT?

Presenter: Bernhard Witzenbichler

October 31, 2013

Presentation TCT 2013

Case Presentation: PCI in a Patient not Represented in Clinical Trials

Presenter: Angela Hoye

October 31, 2013

Presentation TCT 2013

Interventional Management of Cardiogenic Stroke

Presenter: Robert Sommer

October 31, 2013

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation

Bringing It All Together for Device Development/Education and Technique Optimization

Presenter: Liz Perpetua

October 31, 2013

Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

Presentation TCT 2013

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Presenter: Jeffrey Moses

October 31, 2013

Presentation TCT 2013

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Presenter: Giuseppe De Luca

October 31, 2013

Advertisement

Slides

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Case 3: Acute Myocardial Infarction: Is There a Role for Routine IVUS/OCT?

Case Presentation: PCI in a Patient not Represented in Clinical Trials

Interventional Management of Cardiogenic Stroke

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Bringing It All Together for Device Development/Education and Technique Optimization

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content